title: High-throughput drug screening identifies compounds and molecular strategies for targeting proteasome inhibitor-resistant multiple myeloma.
authors.affiliation: Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA.
authors.forename: H A F
authors.initials: HA
authors.lastname: Stessman
authors.affiliation: Department of Medicine, Division of Hematology and Oncology, Penn State Hershey Cancer Institute, Penn State College of Medicine, Hershey, PA, USA.
authors.forename: A
authors.initials: A
authors.lastname: Lulla
authors.affiliation: Department of Electronic and Information Engineering, Huazhong University of Science and Technology, Wuhan, China.
authors.forename: T
authors.initials: T
authors.lastname: Xia
authors.affiliation: Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA.
authors.forename: A
authors.initials: A
authors.lastname: Mitra
authors.affiliation: Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA.
authors.forename: T
authors.initials: T
authors.lastname: Harding
authors.affiliation: Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA.
authors.forename: A
authors.initials: A
authors.lastname: Mansoor
authors.affiliation: Department of Computer Science and Engineering, University of Minnesota, Minneapolis, MN, USA.
authors.forename: C L
authors.initials: CL
authors.lastname: Myers
authors.affiliation: Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA.
authors.forename: B G
authors.initials: BG
authors.lastname: Van Ness
authors.affiliation: Department of Medicine, Division of Hematology and Oncology, Penn State Hershey Cancer Institute, Penn State College of Medicine, Hershey, PA, USA.
authors.forename: N G
authors.initials: NG
authors.lastname: Dolloff
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D001897:Boronic Acids / Q000494:pharmacology*; D000069286:Bortezomib; D019008:Drug Resistance, Neoplasm; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D057166:High-Throughput Screening Assays / Q000379:methods*; D006801:Humans; D051379:Mice; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000201:enzymology; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism*; D011719:Pyrazines / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D004791:Enzyme Inhibitors; D011719:Pyrazines; D000069286:Bortezomib; D046988:Proteasome Endopeptidase Complex